CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures steady as oil jumps to two-week high ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 320.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $320.36 | 52 Week High | $114.49 | |||
| Open | $320.36 | 52 Week Low | $75.17 | |||
| Day High | $320.36 | P/E | 88.74 | |||
| Day Low | $320.36 | EPS | $3.61 | |||
| Volume | 36 | |||||
| (AMEX: CSLLY) | Delayed: 32.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.21 | 52 Week High | $45.60 | |||
| Open | $32.21 | 52 Week Low | $33.39 | |||
| Day High | $32.21 | P/E | N/A | |||
| Day Low | $32.21 | EPS | $0.00 | |||
| Volume | 809 | |||||
